The speed you need

Fast bioanalytical turnaround times — without
compromising quality

Bioanalytical turnaround time matters. Veloxity Labs was built to initiate studies quickly and deliver high-quality data on responsive, predictable timelines — without compromising scientific rigor.

Why speed matters

Timely data. Faster decisions. Fewer avoidable delays.

In drug development, time is a critical variable. Delays in bioanalytical data can stall decisions, disrupt study timelines and add cost. Veloxity specializes in rapid, reliable bioanalysis designed to help teams get the data they need when development decisions depend on it.

Industry benchmarking

Built to avoid common bioanalytical bottlenecks

Backlogs, capacity constraints and operational bottlenecks can delay study starts and data delivery. Veloxity’s operating model intentionally maintains available capacity to support rapid project initiation and responsive study execution.

Faster starts

Project launch in 5 days

Veloxity launches most projects within five business days of materials receipt. Our streamlined workflows and available capacity are designed to reduce startup delays and get studies moving quickly.

Decision confidence

Timely data. Smarter decisions.

Your ability to make informed decisions depends on timely data. Faster turnaround can reduce the time between dosing and data review, helping teams make study
decisions sooner.

Risk, reduced

Early data = early risk mitigation

Timely bioanalytical data can help teams identify unexpected findings, interactions or formulation issues earlier, when there may be more opportunity
to respond.

Budget control

Stay on track, save on costs

Extended delays can contribute to idle resources, timeline creep and avoidable costs. Predictable bioanalytical timelines can help teams coordinate downstream activities more effectively.

Competitive edge

Move fast. Stay ahead.

Every day matters in drug development. Timely bioanalytical data can support faster internal decision-making and help teams prepare for the next
development milestone.

Built for reliability

Speed without sacrificing quality

At Veloxity, speed and quality go hand in hand. Experienced scientists, defined workflows and rigorous QA processes support accurate, traceable and audit-ready bioanalytical data.

Built for rapid turnaround

Infrastructure and process designed to deliver

80% capacity model maintains room for rapid project starts
Integrated bioanalysis and PK/TK analysis with automated NCA
Purpose-built lab with redundant systems supporting workflow continuity
Our proprietary VELO™ workflow system streamlines project tracking, sample chain of custody and QA workflows
Expert team with deep GLP/GCP and regulatory experience

Speed meets accuracy

Speed Meets Accuracy: Fast Turnaround Times and Precise Data in Bioanalysis

Download the report to explore why bioanalytical turnaround time matters, the factors that influence study timelines and the operational approaches Veloxity uses to support rapid project initiation and reliable data delivery.

Report

Accelerating Drug Development Along the Entire Lifecycle

Co-authored with sponsor/end-user Andy Vick, PhD (BlueWater Biosciences), this practical guide shows how to keep LC–MS/MS in lockstep from discovery through clinical so decisions land on schedule. You’ll get phase-aligned method design, clear BioA → PK handoffs, microsampling/small-volume strategies and checklists that protect turnaround times with documentation aligned to GLP/GCP and ICH M10.

Have a study that needs to move quickly?

Tell us your study requirements and target timeline. Our team can help you determine the fastest practical path to project initiation and reliable bioanalytical data.